BusinessCure Pharmaceutical Enters Into Product Development Agreement with Therapix Biosciences To Develop Cannabinoid-Based Product For Sleep DisordersBy Nasdaq OMXNov 7, 2017, 2:00 PM UTC
BusinessCURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.By Nasdaq OMXMay 24, 2017, 1:12 PM UTC
BusinessCURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.By Nasdaq OMXMay 24, 2017, 1:11 PM UTC
BusinessCURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.By Nasdaq OMXMay 24, 2017, 1:11 PM UTC
BusinessCURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.By Nasdaq OMXMay 24, 2017, 1:11 PM UTC
BusinessCURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.By Nasdaq OMXMay 24, 2017, 1:11 PM UTC
BusinessCURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.By Nasdaq OMXMay 24, 2017, 1:11 PM UTC
BusinessCURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.By Nasdaq OMXMay 24, 2017, 1:11 PM UTC
